 "Dr Reddy's")
Shares of Dr Reddy’s Laboratories hit a 52-week high of Rs 2,760 apiece, up 1.3 per cent on BSE in the intra-day trade on Friday, ahead of December quarter results (Q3FY19) today. The drug company surpassed its previous high of Rs 2,745 recorded on December 3, 2018 in the intra-day deal.
Since October 26, post September quarter (Q2FY19) results, Dr Reddy’s has outperformed the market by 14 per cent, as compared to a 9 per cent rise in the S&P BSE Sensex.
The company’s earnings over the last year have been adversely impacted by competition in some key products
Since October 26, post September quarter (Q2FY19) results, Dr Reddy’s has outperformed the market by 14 per cent, as compared to a 9 per cent rise in the S&P BSE Sensex.
The company’s earnings over the last year have been adversely impacted by competition in some key products
